renal hypertensive rats
Recently Published Documents


TOTAL DOCUMENTS

220
(FIVE YEARS 0)

H-INDEX

26
(FIVE YEARS 0)

2018 ◽  
Vol 122 ◽  
pp. 125-133 ◽  
Author(s):  
T.D. Paula ◽  
B.R. Silva ◽  
M.D. Grando ◽  
H.C.D. Souza ◽  
L.M. Bendhack

2016 ◽  
Vol 4 (16) ◽  
pp. e12900 ◽  
Author(s):  
Shan Gao ◽  
Byung M. Park ◽  
Seung A. Cha ◽  
Ui J. Bae ◽  
Byung H. Park ◽  
...  

2016 ◽  
Vol 35 (1) ◽  
pp. 15-21 ◽  
Author(s):  
Seok Choi ◽  
Kwon Ho Ryu ◽  
Sang Hag Park ◽  
Jae Yeoul Jun ◽  
Byung Chul Shin ◽  
...  

2014 ◽  
Vol 153 (3) ◽  
pp. 635-640 ◽  
Author(s):  
Wen-ting Zhou ◽  
Adil Abdurahman ◽  
Elzira Abdusalam ◽  
Wuliya Yiming ◽  
Parida Abliz ◽  
...  

2014 ◽  
Vol 152 (3) ◽  
pp. 464-469 ◽  
Author(s):  
Wenting Zhou ◽  
Elzira Abdusalam ◽  
Parida Abliz ◽  
Nadira Reyim ◽  
Shuge Tian ◽  
...  

2014 ◽  
Vol 33 (1) ◽  
pp. 19-25 ◽  
Author(s):  
Seok Choi ◽  
Hye Rang Shin ◽  
Sang Hoon Kim ◽  
Mi Jung Lee ◽  
Jae Yeoul Jun ◽  
...  

2013 ◽  
Vol 803 ◽  
pp. 113-117
Author(s):  
Ya Jing Da ◽  
Zhi Long Chen

A novel nonpeptide angiotensin II receptor 1 antagonist, compound 1, N-butyryl-N-[(2'-(2, 5-dihydro-5-oxo-1, 2, 4-oxadiazol-3-yl) biphenyl-4-yl) methy-L-Valine was investigated by receptor-binding studies and vivo experiments in spontaneously hypertensive rats and renal hypertensive rats. Furthermore, treatment with compound 1 significantly inhibited the viability of human breast cancer cell line and promoted apoptosis of the cancer cells. The compound had the effects of anti-hypertension and anti-cancer, which suggested that this new compound could be considered as a candidate for both novel anti-hypertensive and anti-cancer agent.


2012 ◽  
Vol 31 (4) ◽  
pp. 227-233 ◽  
Author(s):  
Seok Choi ◽  
Hyun Il Kim ◽  
Sang Hag Park ◽  
Mi Jung Lee ◽  
Jae Yeoul Jun ◽  
...  

2012 ◽  
Vol 60 (2) ◽  
pp. 193-198 ◽  
Author(s):  
Gerson J. Rodrigues ◽  
Amanda C. Pereira ◽  
Juliana A. Vercesi ◽  
Renata G. Lima ◽  
Roberto S. Silva ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document